Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lung Cancer - a podcast by ReachMD

CME credits: 0.25

Valid until: 15-07-2021

Claim your CME credit at https://reachmd.com/programs/cme/keeping-pace-lung-cancer-use-immunotherapy-mutation-positive-non-small-cell-lung-cancer/11723/

Advanced non-small cell lung cancer (NSCLC) remains incurable; however, advances in treatment and new insights into the molecular pathogenesis of the disease have led to the development of treatments that significantly extend overall survival.

This discussion between Drs. Mark Socinski and Gilberto de Lima Lopes reviews the emerging scientific and clinical data on the role of immunotherapy in mutation-positive NSCLC. Tune in to discover how these therapeutics can benefit your patients.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD